Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Breast Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 115 articles: HTML format Text format

Single Articles

March 2010
1. BAKKEN K , Fournier A, Lund E, Waaseth M, et al
   Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European prospective investigation into cancer and nutrition (EPIC).
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. STENDAHL M , Nilsson S, Wigerup C, Jirstrom K, et al
   p27(Kip1) is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. BIGHIN C , Mastro LD, Canavese G, Carli F, et al
   Use in current clinical practice of 70-gene signature in early breast cancer.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles   
   
   
   
4. MOLLER H , Sandin F, Bray F, Klint A, et al
   Breast cancer survival in England, Norway and Sweden: A population-based comparison.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. ALMQUIST M , Bondeson AG, Bondeson L, Malm J, et al
   Serum levels of vitamin D, PTH, calcium and breast cancer risk - a prospective nested case-control study.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. YUE W , Wang JP, Li Y, Fan P, et al
   Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. POGRIBNY IP , Filkowski JN, Tryndyak VP, Golubov A, et al
   Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. FLEUREN ED , O'Toole S, Millar EK, McNeil C, et al
   Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. LAXMI YR , Liu X, Suzuki N, Kim SY, et al
   Anti-breast cancer potential of SS1020, a novel antiestrogen lacking estrogenic and genotoxic actions.
   Int J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. LI C , Cao S, Liu Z, Ye X, et al
    RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through ERK pathway in breast cancer cells.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
11. MAILLARD V , Kuriki K, Lefebvre B, Boutron-Ruault MC, et al
    Serum carotenoid, tocopherol and retinol concentrations and breast cancer risk in the E3N-EPIC study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. CHU R , Zhao X, Griffin C, Staub RE, et al
    Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor-negative breast cancer cells by BN107 and oleanolic acid.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. FISCHGRABE J , Gotte M, Michels K, Kiesel L, et al
    Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. SUZUKI R , Iwasaki M, Inoue M, Sasazuki S, et al
    Alcohol consumption-associated breast cancer incidence and potential effect modifiers - The Japan public health center-based prospective study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. GREEN AK , Hankinson SE, Bertone-Johnson ER, Tamimi RM, et al
    Mammographic density, plasma vitamin D levels, and risk of breast cancer in postmenopausal women.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. NIMEUS-MALMSTROM E , Koliadi A, Ahlin C, Holmqvist M, et al
    Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
17. SAARINEN NM , Abrahamsson A, Dabrosin C
    Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. ROY PG , Pratt N, Purdie CA, Baker L, et al
    High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. DZIAMAN T , Huzarski T, Gackowski D, Rozalski R, et al
    Elevated level of 8-oxo-7,8-dihydro-2'-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls.
    Int J Cancer. 2009;125:2209-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
20. BINAI NA , Damert A, Carra G, Steckelbroeck S, et al
    Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. LYYTINEN H , Dyba T, Pukkala E, Ylikorkala O, et al
    Do the dose or route of administration of norethisterone acetate as a part of hormone therapy play a role in risk of breast cancer: Nation-wide case-control study from Finland.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. HEMMINKI K , Muller-Myhsok B, Lichtner P, Engel C, et al
    Low risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. TRYNDYAK VP , Beland FA, Pogribny IP
    E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. FURLANETTO TW
    Vitamin D2 could be one of the protective phytochemicals.
    Int J Cancer. 2009;125:1994.
    PubMed     Text format     Related articles   
    
    
    
25. DEN OUDSTEN BL , Van Heck GL, Van der Steeg AF, Roukema JA, et al
    Second operation is not related to psychological outcome in breast cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. YANG ZQ , Liu G, Bollig-Fischer A, Haddad R, et al
    Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.
    Int J Cancer. 2009;125:1613-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. RIEBER M , Strasberg Rieber M
    DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.
    Int J Cancer. 2009;125:1604-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
28. RYDEN L , Grabau D, Schaffner F, Jonsson PE, et al
    Evidence for tissue factor phosphorylation and its correlation with protease activated receptor expression and the prognosis of primary breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. CHENG JM , Volk L, Janaki DK, Vyakaranam S, et al
    Tumor suppressor function of Rab25 in triple negative breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. FUJIMOTO H , Sangai T, Ishii G, Ikehara A, et al
    Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
    Int J Cancer. 2009;125:1276-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. GUTTERIDGE E , Agrawal A, Nicholson R, Cheung KL, et al
    The effects of gefitinib in tamoxifen resistant and hormone insensitive breast cancer: A phase II study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. ELAZAR V , Adwan H, Bauerle T, Rohekar K, et al
    Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. ABBAS S , Brauch H, Chang-Claude J, Dunnebier T, et al
    Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. STAJNERM I
    Season of breast cancer diagnosis and probability of death from breast cancer in the united states.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
35. ZHOU Y , Chen H, Ma XL, Xie HJ, et al
    Fusion protein of adenovirus E4orf4 and human epidermal growth factor inhibits tumor cell growth.
    Int J Cancer. 2009;125:1186-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
36. ALESKANDARANY MA , Green AR, Rakha EA, Mohammed RA, et al
    Growth fraction as a predictor of response to chemotherapy in node negative breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. NADERI A , Liu J, Bennett IC
    BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. IKEBUCHI K , Chano T, Ochi Y, Tameno H, et al
    RB1CC1 activates the promoter and expression of RB1 in human cancer.
    Int J Cancer. 2009;125:861-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. LOPEZ-KNOWLES E , O'Toole SA, McNeil CM, Millar EK, et al
    PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. KISCHEL P , Waltregny D, Dumont B, Turtoi A, et al
    Versican overexpression in human breast cancer lesions: Known and new isoforms for stromal tumor targeting.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. LU J , Fan T, Zhao Q, Zeng W, et al
    Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. SAHNI A , Arevalo MT, Sahni SK, Simpson-Haidaris PJ, et al
    The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells.
    Int J Cancer. 2009;125:577-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. FILLMORE RA , Mitra A, Xi Y, Ju J, et al
    Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.
    Int J Cancer. 2009;125:556-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. DUNNEBIER T , Bermejo JL, Haas S, Fischer HP, et al
    Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade.
    Int J Cancer. 2009;125:596-602.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
45. LAU WM , Weber KL, Doucet M, Chou YT, et al
    Identification of prospective factors promoting osteotropism in breast cancer: A potential role for CITED2.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. GIBSON LJ , Hery C, Mitton N, Gines-Bautista A, et al
    Risk factors for breast cancer among Filipino women in Manila.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. OTTEWELL PD , Lefley DV, Cross SS, Evans CA, et al
    Sustained inhibition of tumour growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. GHAYAD SE , Vendrell JA, Larbi SB, Dumontet C, et al
    Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. WANG T , Lv JH, Zhang XF, Li CJ, et al
    Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. DESFRANCOIS J , Derre L, Corvaisier M, Le Mevel B, et al
    Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusions.
    Int J Cancer. 2009;125:374-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. LYYTINEN HK , Dyba T, Ylikorkala O, Pukkala EI, et al
    A case-control study on hormone therapy as a risk factor for breast cancer in finland: Intrauterine system carries a risk as well.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. WU MH , Chou YC, Chou WY, Hsu GC, et al
    Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: Evidence from a case-control study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
53. TANG X , Zhang Q, Shi S, Yun Y, et al
    Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. GUO P , Dong XY, Zhao KW, Sun X, et al
    Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. XIE L , Brisson J, Holowaty E, Villeneuve PJ, et al
    The influence of cosmetic breast augmentation on the stage distribution and prognosis of women subsequently diagnosed with breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. PROMKAN M , Liu G, Patmasiriwat P, Chakrabarty S, et al
    BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. UDLER MS , Azzato EM, Healey CS, Ahmed S, et al
    Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. KIOULAFA M , Balkouranidou I, Sotiropoulou G, Kaklamanis L, et al
    Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. KIM SH , Miller FR, Tait L, Zheng J, et al
    Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression.
    Int J Cancer. 2009;124:2813-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. CHEN C , Zhou Z, Sheehan CE, Slodkowska E, et al
    Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.
    Int J Cancer. 2009;124:2829-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. KABAT GC , Kim M, Caan BJ, Chlebowski RT, et al
    Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. EDMONDS MD , Hurst DR, Vaidya KS, Stafford LJ, et al
    Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. KUO YC , Su CH, Liu CY, Chen TH, et al
    Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase.
    Int J Cancer. 2009;124:2568-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
64. KEET AW , Al-Rafae M, Chappuis PO, Brunet JS, et al
    Long-term outcome after neo-adjuvant chemotherapy for breast cancer in BRCA1/2 carriers.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
65. FUKAZAWA T , Maeda Y, Matsuoka J, Tanaka N, et al
    Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. CHARPIN C , Secq V, Giusiano S, Carpentier S, et al
    A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays.
    Int J Cancer. 2009;124:2124-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. JUSTENHOVEN C , Pierl CB, Haas S, Fischer HP, et al
    Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors.
    Int J Cancer. 2009;124:2077-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. NJOR SH , Pedersen AT, Schwartz W, Hallas J, et al
    Minimizing misclassification of hormone users at mammography screening.
    Int J Cancer. 2009;124:2159-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. SOHN KJ , Jang H, Campan M, Weisenberger DJ, et al
    The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification.
    Int J Cancer. 2009;124:1999-2005.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
70. ZHANG Y , Su H, Rahimi M, Tochihara R, et al
    EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. VAN DEN EYNDEN GG , Van Laere SJ, Van der Auwera I, Trinh XB, et al
    Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
72. KARMAKAR S , Foster EA, Smith CL
    Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor.
    Int J Cancer. 2009;124:1841-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. KAWASE T , Matsuo K, Suzuki T, Hiraki A, et al
    FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: Results of a case control study in Japan.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. MCSHERRY EA , McGee SF, Jirstrom K, Doyle EM, et al
    JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. GOLUBOVSKAYA VM , Conway-Dorsey K, Edmiston SN, Tse CK, et al
    FAK overexpression and p53 mutations are highly correlated in human breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. BUTT S , Borgquist S, Anagnostaki L, Landberg G, et al
    Parity and age at first childbirth in relation to the risk of different breast cancer subgroups.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. O'MALLEY S , Su H, Zhang T, Ng C, et al
    TOB suppresses breast cancer tumorigenesis.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. KOTSOPOULOS J , Tworoger SS, Devivo I, Hankinson SE, et al
    +331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. DEY S , Boffetta P, Mathews A, Brennan P, et al
    Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. MASALA G , Assedi M, Ambrogetti D, Sera F, et al
    Physical activity and mammographic breast density in a Mediterranean population: the EPIC Florence longitudinal study.
    Int J Cancer. 2009;124:1654-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
81. SANGRAJRANG S , Sato Y, Sakamoto H, Ohnami S, et al
    Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. GAJALAKSHMI V , Mathew A, Brennan P, Rajan B, et al
    Breastfeeding and breast cancer risk in India: A multicenter case-control study.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. MCCOLGAN P , Sharma P
    Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. BOGAN C , Chen J, O'Sullivan MG, Cormier RT, et al
    Loss of EphA2 receptor tyrosine kinase reduces ApcMin/+ tumorigenesis.
    Int J Cancer. 2009;124:1366-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. BERTUCCI F , Finetti P, Cervera N, Charafe-Jauffret E, et al
    How different are luminal A and basal breast cancers?
    Int J Cancer. 2009;124:1338-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. DE STEFANI E , Deneo-Pellegrini H, Boffetta P, Ronco AL, et al
    Dietary patterns and risk of cancer: a factor analysis in Uruguay.
    Int J Cancer. 2009;124:1391-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. SRINIVASAN S , Koduru S, Kumar R, Venguswamy G, et al
    Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. YE L , Gho WM, Chan FL, Chen S, et al
    Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase.
    Int J Cancer. 2009;124:1028-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
89. FUJITA T , Liu W, Doihara H, Wan Y, et al
    An in vivo study of Cdh1/APC in breast cancer formation.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. PETERSON NB , Beeghly-Fadiel A, Gao YT, Long J, et al
    Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. MOORE AB , Shannon J, Chen C, Lampe JW, et al
    Dietary and stored iron as predictors of breast cancer risk: A nested case-control study in Shanghai.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. JANG JH , Cotterchio M, Gallinger S, Knight JA, et al
    Family history of hormonal cancers and colorectal cancer risk: A case-control study conducted in Ontario.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. HYDER SM , Liang Y, Wu J
    Estrogen regulation of thrombospondin-1 in human breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. TERRASI M , Fiorio E, Mercanti A, Koda M, et al
    Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. ZHANG CX , Ho SC, Chen YM, Fu JH, et al
    Greater vegetable and fruit intake is associated with a lower risk of breast cancer among Chinese women.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. WRIGHT TG , Singh VK, Li JJ, Foley JH, et al
    Increased production and secretion of HGF alpha-chain and an antagonistic HGF fragment in a human breast cancer progression model.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. VARNA M , Lehmann-Che J, Turpin E, Marangoni E, et al
    p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors.
    Int J Cancer. 2009;124:991-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. QI C , Zhu YT, Hu L, Zhu YJ, et al
    Identification of Fat4 as a candidate tumor suppressor gene in breast cancers.
    Int J Cancer. 2009;124:793-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. LARSSON SC , Bergkvist L, Wolk A
    Glycemic load, glycemic index and breast cancer risk in a prospective cohort of Swedish women.
    Int J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. MIGNONE LI , Giovannucci E, Newcomb PA, Titus-Ernstoff L, et al
     Dietary carotenoids and the risk of invasive breast cancer.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. HOLLOSI P , Yakushiji JK, Fong KS, Csiszar K, et al
     Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
102. KULASINGAM V , Zheng Y, Soosaipillai A, Leon AE, et al
     Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. CHEN YT , Hsu M, Lee P, Shin SJ, et al
     Cancer/testis antigen CT45: Analysis of mRNA and protein expression in human cancer.
     Int J Cancer. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. LIPWORTH L , Tarone RE, Friis S, Ye W, et al
     Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study.
     Int J Cancer. 2009;124:490-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
105. WOODS LM , Rachet B, O'Connell D, Lawrence G, et al
     Large differences in patterns of breast cancer survival between Australia and England: A comparative study using cancer registry data.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. ADELAIDE J , Finetti P, Charafe-Jauffret E, Wicinski J, et al
     Absence of ESR1 amplification in a series of breast cancers.
     Int J Cancer. 2008;123:2970-2.
     PubMed     Text format     Related articles   
     
     
     
107. GIOTOPOULOS G , Armstrong C, Osman A, Peat I, et al
     Refining the evidence for GSTA1 and eNOS genetic effects on risk of radiotherapy-induced telangiectasia.
     Int J Cancer. 2008;123:2973-4.
     PubMed     Text format     Related articles   
     
     
     
108. KRICKER A , Newman B, Gertig DM, Goumas C, et al
     Why do large breast cancers still present in a population offered screening?
     Int J Cancer. 2008;123:2907-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. BREW CT , Aronchik I, Kosco K, McCammon J, et al
     Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. KABAT GC , Cross AJ, Park Y, Schatzkin A, et al
     Meat intake and meat preparation in relation to risk of postmenopausal breast cancer in the NIH-AARP diet and health study.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
111. LANIGAN F , McKiernan E, Brennan DJ, Hegarty S, et al
     Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
112. SOERJOMATARAM I , de Vries E
     Response: Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles   
     
     
     
113. SWEENEY KJ , Boran S, Fitzpatrick P, Merrigan AB, et al
     Postmenopausal hormone therapy and prevalent round screening mammography.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles   
     
     
     September 2008
114. CONROTTO P , Roesli C, Rybak J, Kischel P, et al
     Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. LEVI F , Randimbison L, Te VC, Conconi MM, et al
     Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
     Int J Cancer. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: